Method of preparing finerenone, intermediate compound of finerenone, and method of preparing the intermediate compound

The method for producing finerenone involves reacting compound 1 with di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid to achieve stable and optically pure finerenone, addressing the challenges of yield and cost in existing processes by using intermediate compounds 2a or 3, which are stable and easily convertible, thus improving productivity and reducing costs.

WO2024246787A1PCT designated stage expired Publication Date: 2024-12-05JW PHARMA CORP
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/IB2024/055237
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-31
Filing Date
2024-05-30
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current methods for producing finerenone face challenges in achieving stable, high-yield, and optically pure production while reducing costs and process time, particularly in mass production.

Method used

The method involves preparing compound 2a or compound 3 using compound 1, which is a racemic mixture, through reactions with di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid under specific organic solvent conditions, followed by desalting and amide coupling to obtain finerenone, thereby simplifying the process and enhancing optical purity.

Benefits of technology

This approach results in finerenone with high production yield and optical purity, and the intermediate compounds (2a or 3) demonstrate excellent stability, facilitating easy optical separation and reducing manufacturing costs by reusing by-products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IB2024055237_05122024_PF_FP_ABST
    Figure IB2024055237_05122024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a method for preparing finerenone, an intermediate compound of finerenone, and a method for preparing same. Finerenone is prepared by using an intermediate compound represented by chemical formula 2a or an intermediate compound represented by chemical formula 3.
Need to check novelty before this filing date? Find Prior Art

Description

[0001]

specification

[0002]

Title of invention

Technical field

[0003]

Background Art

[0004] [Prior Art Literature]

[0005] [Patent Document]

[0006] (Patent Document 1) Korean Patent No. 10-1614164

[0007]

Detailed Description of the Invention

[0008] [Technical Problem] One object of the present invention is to provide a method for producing finerenone with a stable, excellent yield and optical purity. Another object of the present invention is to provide an intermediate compound for producing finerenone and a method for producing the same.

[0009]

Technical Solution

[0010] <Chemical Formula 1>

[0011] In the present invention, compound 1 represented by chemical formula 1 means a racemic mixture including compound la represented by chemical formula la and compound lb represented by chemical formula lb.

[0012] <chemical formula la> <chemical formula lb>

[0013] In one embodiment, the step of preparing compound 2a or compound 3 may include reacting compound 1 with di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid. In the present invention, di-p-toluoyl-D-tartaric acid refers to a compound having the IUPAC name (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinic acid. In the present invention, (-)-camphor-10-sulfonic acid refers to a compound having an IUPAC name of ((lR,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid. In one embodiment, compound 1 and di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid can be reacted in the presence of acetonitrile (ACN). In one embodiment, the step of preparing compound 2a or compound 3 may include a step of reacting compound 1 with di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid at 15 to 90 °C. In one embodiment, the step of reacting compound 1 with di-p-toluoyl-D-tartaric acid under organic solvent conditions may be included. At this time, the organic solvent may be methanol, ethanol, THF, or acetonitrile, and each of these may be used alone or in a mixture of two or more thereof. In one embodiment, when ethanol is used as the organic solvent, ethanol may be used alone or together with water and / or acetone.For example, when ethanol is used as an organic solvent, 100% ethanol, a mixed solvent having a volume ratio of ethanol and water of 70:30, or a mixed solvent having a volume ratio of ethanol and acetone of 50:50 to 70:30 can be used as the organic solvent. In one embodiment, compound 1 and di-p-toluoyl-D-tartaric acid can be reacted under organic solvent conditions including all of ethanol, water, and acetone. In one embodiment, when methanol is used as an organic solvent, methanol may be used alone, or methanol may be used together with ethyl acetate (EA), acetone, methyl acetate (MA), acetonitrile, dichloromethane (DCM), and toluene, methyl tert-butyl ether (MTBE), or methanol may be used together with THF or acetone. In one embodiment, the step of reacting compound 1 with di-p-toluoyl-D-tartaric acid under organic solvent conditions to prepare compound 2a may be represented by the following reaction scheme 1.

[0014] [Reaction Formula 1] In one embodiment, compound 1 and di-p-toluoyl-D-tartaric acid may be mixed in an equivalent ratio of 1:0.5 to 1:3. For example, compound 1 and di-p-toluoyl-D-tartaric acid may be mixed in an equivalent ratio of 1:0.5 to 1:0.6. In one embodiment, compound 1 and di-p-toluoyl-D-tartaric acid may be mixed in an equivalent ratio of 1:0.4 to 1:0.6. For example, compound 1 and di-p-toluoyl-D-tartaric acid may be mixed in an equivalent ratio of 1:0.55. In one embodiment, the step of preparing compound 2a includes the step of mixing compound 1 and di-p-toluoyl-D-tartaric acid with acetonitrile;

[0015] The method may include a step of reacting and refluxing at 70 to 90°C; a step of cooling to a temperature lower than the reaction temperature; and a step of filtering and washing to obtain compound 2a as a solid. In one embodiment, the step of cooling may include a step of first cooling to 40 to 60°C; and a step of second cooling to 20 to 30°C. In one embodiment, the step of reacting and refluxing may be performed at 80°C. The first cooling may be performed at 50°C, and the second cooling may be performed at 20 to 25°C. In one embodiment, in the step of reacting compound 1 and di-p-toluoyl-D-tartaric acid under acetonitrile conditions, acetonitrile may be mixed in a volume of 20 to 100 times the weight of compound 1. In one embodiment, the step of preparing compound 2a may include the step of reacting compound 1 and di-p-toluoyl-D-tartaric acid at 15 to 30°C under organic solvent conditions including either methanol or ethanol; and the step of filtering and washing to obtain compound 2a as a solid. The organic solvent conditions at this time may include methanol alone, ethanol alone, a mixture of ethanol and water, a mixture of ethanol and acetone, a mixture of methanol and THF, or a mixture of ethanol, water, and acetone. Compound 2a as a solid can be easily obtained through a simple process under mild conditions. In one embodiment, when the organic solvent includes ethanol, in the step of mixing compound 1 and di-p-toluoyl-D-tartaric acid with ethanol, ethanol may be mixed in an amount of 150 to 250 times the weight of compound 1. For example, ethanol can be mixed in a volume 200 times the weight of compound 1.In one embodiment, when the organic solvent includes methanol and THF, in the step of mixing compound 1 and di-p-toluoyl-D-tartaric acid with methanol and THF, methanol may be mixed in an amount 25 times the weight of compound 1, and THF may be mixed in an amount 5 to 35 times the weight of compound 1. In one embodiment, the step of preparing compound 2a may include the steps of mixing compound 1 and di-p-toluoyl-D-tartaric acid with methanol and THF; reacting and stirring at 20 to 22°C; and filtering and washing, and drying under vacuum to obtain compound 2a as a solid. In one embodiment, in the step of reacting compound 1 and di-p-toluoyl-D-tartaric acid under methanol and THF conditions, methanol may be mixed in an amount 25 times the weight of compound 1, and THF may be mixed in an amount 15 times the weight of compound 1. In one embodiment, the step of preparing compound 3 may include a step of reacting compound 1 with (-)-camphor-10-sulfonic acid under organic solvent conditions. At this time, the organic solvent may be acetonitrile. In one embodiment, in the step of mixing compound 1 and (-)-camphor-10-sulfonic acid with acetonitrile, acetonitrile may be mixed in an amount 10 times the weight of compound 1. In one embodiment, the step of preparing compound 3 by reacting compound 1 and (-)-camphor-10-sulfonic acid under organic solvent conditions can be represented by the following reaction scheme 2.

[0016] [Reaction Formula 2]

[0017] In one embodiment, compound 1 and (-)-camphor-10-sulfonic acid can be mixed in an equivalent ratio of 1:1 to 1:1.5. For example, compound 1 and (-)-camphor-10-sulfonic acid can be mixed in an equivalent ratio of 1:1.2. In one embodiment, the step of preparing compound 3 includes the step of mixing compound 1 and (-)-camphor-10-sulfonic acid with acetonitrile;

[0018] The step of reacting and refluxing at 70 to 90°C; the step of cooling to a temperature lower than the reaction temperature; and the step of filtering and washing to obtain compound 3 as a solid may include. The cooling step may be performed at 20 to 30°C. In one embodiment, the step of preparing finerenone may include the step of obtaining compound la using compound 2a or compound 3. The step of obtaining compound la using compound 2a or compound 3 may be a desalting process. In one embodiment, the step of obtaining compound la using compound 2a or compound 3 may be performed by reacting by adding disodium phosphate (NH2HP04) under an alcohol aqueous solution condition. At this time, the alcohol aqueous solution may be an ethanol aqueous solution. In one embodiment, in the step of isolating compound la using compound 2a or compound 3, compound la may be obtained as a solid. In one embodiment, the step of preparing finerenone may include the step of performing a desalting process on compound 2a or compound 3 to obtain compound la as a reactant of an amide coupling to obtain finerenone, wherein the step of obtaining finerenone from compound la may be performed by reacting compound la with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 4-dimethylaminopyridine (DMAP), and ammonium hydroxide (NH4OH) in tetrahydrofuran (THF). At this time, the reaction temperature may be 70 to 80°C. In one embodiment, the step of preparing finerenone using compound 2a or compound 3 may be represented by the following reaction scheme 3 or reaction scheme 4.

[0019] [Reaction Formula 3]

[0020] In one embodiment, the step of preparing finerenone may further include a step of obtaining compound 2a or compound 3 using the obtained compound la after the step of obtaining compound la using compound 2a or compound 3, and the step of obtaining compound 2a or compound 3 may be a salting process, and by including this step, the optical purity of finerenone prepared may be increased. In one embodiment, the step of obtaining compound 2a using compound la may include a step of reacting compound la with di-p-toluoyl-D-tartaric acid under organic solvent conditions, and the reaction temperature may be 20 to 22 °C. For example, compound la and di-p-toluoyl-D-tartaric acid may be mixed in an equivalent ratio of 1:0.1 to 1:0.9. In one embodiment, in the step of reacting compound la and di-p-toluoyl-D-tartaric acid in an organic solvent, when methanol is used as the organic solvent, methanol may be used alone or together with THF. For example, when methanol is used alone, methanol may be mixed in a volume 25 times or 50 times the weight of compound la, and when methanol is used together with THF, methanol and THF may be mixed in a volume 8 to 33 times and 2 to 20 times the weight of compound la, respectively. For example, compound la and di-p-toluoyl-D-tartaric acid can be reacted under organic solvent conditions including both methanol and THF, wherein compound la and di-p-toluoyl-D-tartaric acid are mixed in an equivalent ratio of 1:0.8, and methanol and THF can be mixed in a volume 15 times and 5 times the weight of compound la, respectively.In one embodiment, the step of preparing finerenone may include performing a salting process on compound la to obtain compound 2a or compound 3 as a reactant for amide coupling to obtain finerenone without a separate desalting process. In one embodiment, the step of obtaining finerenone using compound 2a or compound 3 as a reactant for amide coupling may be performed by reacting compound 2a or compound 3 with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 4-dimethylaminopyridine (DMAP), and ammonium hydroxide (NH4OH) in ethyl acetate (EA). At this time, the reaction temperature may be 70 to 80 °C. In one embodiment, the step of preparing finerenone using compound 2a or compound 3 may be represented by the following Reaction Scheme 5 or Reaction Scheme 6.

[0021] [Reaction Formula 5]

[0022] [Reaction Formula 6]

[0023] The step of obtaining finerenone using compound 2a or compound 3 according to the above reaction schemes 5 and 6 can perform desalting and amide coupling in one step without a separate desalting step, thereby reducing the number of steps in the method for preparing finerenone. In one embodiment, the method for preparing finerenone according to the present invention can be performed according to the following reaction scheme 7.

[0024] [Reaction Formula 7] In one embodiment, the method for preparing finerenone according to the present invention can be performed according to the following reaction scheme 8.

[0025] [Reaction Formula 8]

[0026] a) obtaining compound 2a represented by formula 2a or compound 3 represented by formula 3 using compound 1 represented by formula 1; b) desalting compound 2a or compound 3 to obtain compound la; c) salting compound la to obtain compound 2a or compound 3; and d) obtaining finerenone using compound 2a or compound 3 as a reactant for amide coupling. The method for preparing finerenone is substantially the same as that described for the step of obtaining compound 2a or compound 3; the step of obtaining compound la and the step of obtaining finerenone using compound 2a or compound 3 as a reactant for amide coupling, and therefore, redundant detailed descriptions are omitted. In one embodiment, compound 1 as a racemic mixture can be prepared by a method known in the art. For example, the racemic mixture compound 1 can be prepared through a process substantially identical to the method described in Example 22A of Korean Patent No. 10-1614164. In one embodiment, the racemic mixture compound 1 can be prepared through the steps of desalting compound 2b represented by chemical formula 2b to obtain compound lb represented by chemical formula lb; and racemizing compound lb.

[0027] <Chemical Formula 2b> At this time, the method for preparing compound 1 can be performed according to the following reaction scheme 9.

[0028] [Reaction Formula 9] In one embodiment, compound 1, which is a racemic mixture, can be prepared through a step of oxidizing compound 2b to obtain compound 5 represented by the following chemical formula 5; and a step of reducing compound 5 to obtain compound 1. Since the reaction is performed in a salt state without a separate desalting process, compound 1 can be obtained in a high yield.

[0029] <Chemical Formula 5> At this time, compound 1 can be prepared according to the following reaction scheme 10.

[0030] [Reaction Formula 1

[0031] In one embodiment, the compound 2b is an embodiment of Korean Patent No. 10-1614164.

[0032] Compound 1, which is manufactured through a process substantially the same as that described in 22A, can be obtained by reacting with di-p-toluoyl-D-tartaric acid. In one embodiment, the method for manufacturing finerenone of the present invention may further include, after at least one of the steps of manufacturing compound 2a and the step of manufacturing finerenone from compound 2a is completed, a step of desalting compound 2b obtained in the step of manufacturing compound 2a to obtain compound lb; a step of racemizing compound lb to manufacture compound 1; a step of manufacturing compound 2a or compound 3 using compound 1; and a step of manufacturing finerenone represented by formula I from compound 2a or compound 3 obtained above. In one embodiment, the step of racemizing compound lb includes a step of performing an oxidation reaction on compound lb; And a step of performing a reduction reaction on the product obtained by the oxidation reaction to obtain a racemic mixture of compound la and compound lb. In one embodiment, the method for preparing finerenone of the present invention may further include a step of oxidizing compound 2b obtained in the step of preparing compound 2a to obtain compound 5 represented by chemical formula 5 after at least one step of the step of preparing compound 2a and the step of preparing finerenone from compound 2a is completed; a step of reducing compound 5 to obtain compound 1 represented by chemical formula 1; a step of preparing compound 2a or compound 3 using compound 1; and a step of preparing finerenone represented by chemical formula I from compound 2a or compound 3 obtained above. In one embodiment, the step of preparing finerenone may include a step of obtaining finerenone by using compound 2a or compound 3 as a reactant of amide coupling.The above method for producing finerenone is substantially the same as that described for the step of producing finerenone using compound 2a or compound 3, so redundant detailed description is omitted. In the method for producing finerenone according to the present invention, compound 2b generated during the production process is not immediately discarded, but can be used as a raw material for producing compound 2a again in the production of compound 1, which ultimately has the advantage of reducing the production cost of finerenone. An intermediate compound for producing finerenone for one purpose of the present invention may be compound 2a represented by the following chemical formula 2a or compound 2b represented by the following chemical formula 2b.

[0033] <Chemical Formula 2a>

[0034] The present invention provides a use of an intermediate compound, Compound 2a or Compound 2b, for producing finerenone and a use of an intermediate compound, Compound 2a or Compound 2b, for producing finerenone. The method for producing Compound 2a is substantially the same as that described for the step of producing Compound 2a in the method for producing finerenone, and therefore, a detailed description thereof will be omitted. That is, Compound 2a can be produced according to the above Reaction Scheme 1. The method for producing Compound 2b is substantially the same as that described for the step of producing Compound 2a in the method for producing finerenone, and therefore, a detailed description thereof will be omitted. That is, Compound 2b can be obtained by reacting Compound 1 with di-p-toluoyl-D-tartaric acid and then separating the product. Compound 2b can be produced according to the above Reaction Scheme 11. [Reaction Scheme 11] An intermediate compound for producing finerenone for one purpose of the present invention is represented by the following chemical formula:

[0035] It may be compound 3 represented by 3.

[0036] <Chemical Formula 3> The present invention provides a use of an intermediate compound, Compound 3, for producing finerenone and a use of the intermediate compound, Compound 3, for producing finerenone. The method for producing Compound 3 is substantially the same as that described for the step of producing Compound 3 among the methods for producing finerenone, and therefore, redundant detailed descriptions are omitted. That is, Compound 2b can be produced according to the above reaction scheme 2. In the present invention, Compound 2a and Compound 3 are each stable substances and can be easily obtained as a solid without a separate purification process. Compound 1, which is a racemic mixture, has low stability, making it difficult to handle and store, but Compound 2a or Compound 3, as an intermediate compound of finerenone, has excellent stability and can be stably and easily used in the process for producing finerenone. For Compound 1, which is a racemic mixture, a solid salt cannot be obtained with any compound other than di-p-toluoyl-D-tartaric acid and (-)-camphor-10-sulfonic acid. In particular, even if tartaric acid or D-(+)-camphoric acid is used as a substance having a similar structure, a solid salt cannot be obtained by reacting with compound 1, which is a racemic mixture. The method for preparing compound 1 represented by chemical formula 1 according to the present invention includes the steps of desalting compound 2b to obtain compound lb represented by chemical formula lb; and the steps of racemizing compound lb to obtain compound 1. In one embodiment, the step of racemizing compound lb includes the step of oxidizing compound lb; and the step of reducing the product obtained by the oxidation reaction, and compound 1 may include compound 1a and compound lb. In one embodiment, in the step of oxidizing compound lb, compound 4 represented by chemical formula 4 below can be obtained. Compound 4 may be a racemic mixture having achirality, and compound 1 can be obtained by reducing compound 4.

[0037] <Chemical Formula 4> The method for preparing compound 1 represented by chemical formula 1 according to the present invention includes the steps of: oxidizing compound 2b to prepare compound 5 represented by chemical formula 5; and reducing compound 5 to prepare compound 1 represented by chemical formula 1. In one embodiment, in the step of oxidizing compound 2b, compound 5 represented by chemical formula 5 below can be obtained.

[0038] <Chemical Formula 5>

[0039] In one embodiment, the step of preparing compound 5 may be performed by reacting compound 2b with ceric ammonium nitrate (CAN) under organic solvent conditions. At this time, the organic solvent may be acetonitrile. In one embodiment, the step of preparing compound 5 may include: reacting compound 2b with ceric ammonium nitrate in the presence of acetonitrile; extracting with ethyl acetate (EA) and water; and vacuum-drying the concentrated residue to obtain compound 5 as a solid. In one embodiment, in the step of reacting compound 2b with ceric ammonium nitrate in the presence of acetonitrile, compound 2b and ceric ammonium nitrate may be mixed in an equivalent ratio of 1:1.5, and acetonitrile may be mixed in a volume 40 times the weight of compound 2b. In one embodiment, the step of reacting compound 2b with ceric ammonium nitrate under acetonitrile may be performed for 1 to 3 hours and may be performed at room temperature. In one embodiment, the step of obtaining compound 1 may be performed by reacting compound 5, zinc powder, and ammonium formate under organic solvent conditions. At this time, the organic solvent may be THF. In one embodiment, the step of obtaining compound 1 may be performed by,

[0040] A step of reacting compound 5, zinc powder and ammonium formate under THF and refluxing;

[0041] A step of cooling to 20°C and then filtering the zinc powder; a step of extracting by adding ethyl acetate (EA), water, and NaCl aqueous solution; a step of adding MgS04 to the ethyl acetate (EA) layer, filtering, and concentrating; and a step of adding acetonitrile to the concentrated residue and refluxing;

[0042] A step of slowly cooling to 20 °C and then mixing; and a step of washing with acetonitrile, filtering the solid, and drying under vacuum to obtain compound 1 as a solid. In one embodiment, in the step of reacting compound 5 with zinc powder and ammonium formate under THF and refluxing, compound 5, zinc powder, and ammonium formate may be mixed in an equivalent ratio of 1:15:15, and THF may be mixed in a volume 25 times the weight of compound 5. In one embodiment, the step of reacting compound 5 with zinc powder and ammonium formate under THF and refluxing may be performed for 1 to 2 hours.

[0043] 1) The present invention provides a method for preparing finerenone, comprising the steps of preparing compound 2a represented by chemical formula 2a or compound 3 represented by chemical formula 3 using compound 1 represented by chemical formula 1; and preparing finerenone represented by chemical formula I from compound 2a or compound 3.

[0044] <Chemical Formula 1>

[0045]

[0046] <Chemical Formula 3>

[0047] <Chemical Formula I>

[0048]

[0049] 2) In 1), the step of preparing compound 2a or compound 3 may include a step of reacting compound 1 with di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid.

[0050] 3) In 2), compound 1 and di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid may be reacted under acetonitrile.

[0051] 4) In any one of 1) to 3), the step of preparing compound 2a or compound 3 may include a step of reacting compound 1 with di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid at 15 to 90 °C.

[0052] 5) In any one of 1) to 4), the step of preparing compound 2a may include a step of reacting compound 1 and di-p-toluoyl-D-tartaric acid in the presence of at least one organic solvent selected from the group consisting of methanol, ethanol, THF, and acetonitrile.

[0053] 6) In any one of 1) to 5), the step of preparing compound 3 may include a step of reacting compound 1 with (-)-camphor-10-sulfonic acid in acetonitrile.

[0054] 7) In 6), acetonitrile may be mixed in a volume 10 times the weight of compound 1.

[0055] 8) In any one of 1) to 7), the step of preparing the finerenone may include a step of obtaining compound la represented by chemical formula la using compound 2a or compound 3.

[0056] <chemical formula la>

[0057] 9) In 8), the step of obtaining the compound la may be to perform a reaction by adding disodium phosphate (NH2HP04) under an alcohol aqueous solution condition.

[0058] 10) In any one of 1) to 9), the step of preparing finerenone may include a step of obtaining finerenone by using compound 2a or compound 3 as a reactant of amide coupling.

[0059] 11) In any one of 1) to 10), the step of obtaining finerenone using compound 2a or compound 3 as a reactant of amide coupling may be performed by reacting 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 4-dimethylaminopyridine (DMAP) and ammonium hydroxide (NH40H) with compound 2a or compound 3 in ethyl acetate (EA).

[0060] 12) In any one of 8) to 11), the step of preparing finerenone may further include a step of forming a salt of the obtained compound la to prepare compound 2a or compound 3.

[0061] 13) In 12), the step of preparing compound 2a may include a step of reacting compound la and di-p-toluoyl-D-tartaric acid in an equivalent ratio of 1:0.1 to 1:0.9. 14) In 12) or 13), the step of preparing compound 2a may include reacting compound la and di-

[0062] It may include a step of reacting P-toluoyl-D-tartaric acid in the presence of at least one organic solvent selected from the group consisting of methanol and THF.

[0063] 15) In any one of 8) to 14), the step of preparing finerenone may further include a step of obtaining compound 2a or compound 3 using compound la after the step of obtaining compound la using compound 2a or compound 3, wherein the step of obtaining compound 2a using compound la may include a step of reacting compound la with di-p-toluoyl-D-tartaric acid under organic solvent conditions, and compound la and di-p-toluoyl-D-tartaric acid may be reacted under organic solvent conditions including both methanol and THF, wherein compound la and di-p-toluoyl-D-tartaric acid are mixed in an equivalent ratio of 1:0.8, and methanol and THF may be mixed in a volume 15 times and 5 times the weight of compound la, respectively.

[0064] 16) In any one of 1) to 15), the method for producing finerenone may further include a step of oxidizing compound 2b represented by chemical formula 2b to obtain compound 5 represented by chemical formula 5 below; and a step of reducing compound 5 to obtain compound 1 represented by chemical formula 1.

[0065] 17) In any one of 1) to 16), the step of preparing finerenone may include a step of obtaining finerenone by using compound 2a or compound 3 as a reactant of amide coupling.

[0066] 18) The present invention provides an intermediate compound for producing finerenone, which is compound 2a represented by the following chemical formula 2a or compound 2b represented by the following chemical formula 2b.

[0067] <Chemical Formula 2a>

[0068] 19) The present invention provides a method for preparing an intermediate compound for preparing finerenone, comprising the step of reacting compound 1 represented by chemical formula 1 with di-p-toluoyl-D-tartaric acid to prepare compound 2a represented by chemical formula 2a or compound 2b represented by chemical formula 2b:

[0069] <Chemical Formula 1>

[0070] <Chemical Formula 2b>

[0071]

[0072] 20) The present invention provides an intermediate compound for the production of finerenone, represented by the following chemical formula 3:

[0073] <Chemical Formula 3>

[0074] 21) The present invention provides a method for producing an intermediate compound for producing finerenone, comprising the step of reacting compound 1 represented by chemical formula 1 with (-)-camphor-10-sulfonic acid to produce compound 3 represented by chemical formula 3:

[0075] <Chemical Formula 1>

[0076]

[0077] 22) The present invention provides a method for preparing compound 1 represented by chemical formula 1, comprising the steps of: oxidizing compound 2b represented by chemical formula 2b to obtain compound 5 represented by chemical formula 5; and reducing compound 5 to obtain compound 1 represented by chemical formula 1.

[0078] <Chemical Formula 2b>

[0079] 23) In 22), the step of obtaining the compound 5 may be performed by reacting compound 2b with ceric ammonium nitrate (CAN) under organic solvent conditions. At this time, the organic solvent may be acetonitrile.

[0080] 24) In 22) or 23), the step of obtaining compound 5 may include the steps of reacting compound 2b with ceric ammonium nitrate under acetonitrile; extracting by adding ethyl acetate (EA) and water; and drying the concentrated residue in vacuum to obtain compound 5 as a solid.

[0081] 25) In 24), in the step of reacting compound 2b with ceric ammonium nitrate under acetonitrile, compound 2b and ceric ammonium nitrate may be mixed in an equivalent ratio of 1:1.5, and acetonitrile may be mixed in a volume 40 times the weight of compound 2b, and further, the step may be performed at room temperature for 1 to 3 hours; and / or in the step of extracting from ethyl acetate (EA) and water, ethyl acetate (EA) and water may each be mixed in a volume 20 times the weight of compound 2b, and further, water in a volume 20 times the weight of compound 2b may be added to the ethyl acetate (EA) layer to re-extract.

[0082] 26) In any one of 22) to 25), the step of obtaining compound 1 may be performed by reacting compound 5, zinc powder, and ammonium formate under organic solvent conditions. At this time, the organic solvent may be THF. 27) In any one of 22) to 26), the step of obtaining compound 1 may include: reacting compound 5, zinc powder, and ammonium formate under THF and refluxing; cooling to 20°C and then filtering the zinc powder; adding ethyl acetate (EA), water, and an aqueous NaCl solution to extract; adding MgS04 to the ethyl acetate (EA) layer, filtering, and concentrating; and adding acetonitrile to the concentrated residue and refluxing; slowly cooling to 20°C and then mixing; And it may include a step of obtaining compound 1 as a solid by washing with acetonitrile, filtering the solid, and then drying it under vacuum.

[0083] 28) In any one of 22) to 27), in the step of reacting compound 5 with zinc powder and ammonium formate under THF and refluxing, compound 5, zinc powder and ammonium formate may be mixed in an equivalent ratio of 1: 15: 15, THF may be introduced in a volume 25 times the weight of compound 5, and additionally, the refluxing step may be performed for 1 to 2 hours; and in the step of extracting by introducing ethyl acetate (EA), water and NaCl aqueous solution, ethyl acetate (EA), water and NaCl aqueous solution may be introduced in an amount of 20 times, 20 times and 20 times the weight of compound 5.

[0084] Can be mixed in a volume 10 times that of compound 5, and can be re-extracted by adding water in a volume 20 times that of the weight of compound 5 to the ethyl acetate (EA) layer; In the step of adding MgS04 to the ethyl acetate (EA) layer and filtering and concentrating, MgS04 can be mixed in an amount 3 times that of compound 5, and can be further stirred for 5 minutes, filtered and concentrated; In the step of adding acetonitrile to the concentrated residue and refluxing, acetonitrile can be mixed in an amount 2 times that of compound 5, and can be further refluxed for 0.5 to 1 hour; and / or in the step of washing with acetonitrile, filtering the solid, and drying under vacuum to obtain compound 1 as a solid, acetonitrile can be used in an amount 2 times that of compound 5.

[0085]

Effect of the Invention

[0086]

Form for Embodiment of the Invention

[0087] 2.44(m, 10H), 3.41 - 3.47(m, 2H), 3.73(s, 3H), 3.97 - 4.10 (m, 2H), 4.37 (br s,

[0088] IH), 5.32(s, IH), 5.82(s, 2H), 7.24 - 7.30(m, 2H), 7.31(s, IH), 7.41(d, J=1 W

[0089] Hz, 4H), 7.57(s, IH), 7.90(d, 8.30 Hz, 4H), 8.16(s, IH).

[0090] (Step 2) (S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6 ■ Preparation of naphthyridine-3-carboxylic acid (compound la) Compound 2a (10 g, 1 eq) obtained in the above step 1 was added to a 25% ethanol aqueous solution (100 ml) in a volume 10 times the weight of compound 2a, then 10% Na2HP04 (150 to 250 ml) was added in a volume 15 to 25 times the weight of compound 2a, stirred at 5 to 25°C for 1 to 5 hours, and when the reaction was complete, water (500 ml) was added and filtered. The filtered product was washed with 25% aqueous ethanol solution (50 ml) in a volume 5 times the weight of compound 2a, and the obtained solid was vacuum-dried to obtain the title compound (overall yield of step 1 and step 2: 39.90%).

[0091] (Step 3) In step 3 of manufacturing finerenone, compound la (10 g, 1.0 eq) obtained in step 2, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI, 7.58 g, 1.5 eq), 4-dimethylaminopyridine (DMAP, 483 mg, 1.5 eq), and 25% NH40H aqueous solution (21 ml, 5 eq) were added to tetrahydrofuran (THF) in a volume (100 ml) 10 times the weight (10 g) of compound la to be used, and then the temperature was raised to 70 to 80°C and refluxed. After 1 to 2 hours, when compound la remains less than 1%, the reaction is terminated and each is worked up using ethyl acetate (EA) (200 ml) and water (200 ml) in a volume 20 times the weight of compound la, and the mixture is concentrated. Ethanol (50 ml) is added in a volume 5 times the weight of compound la, and concentrated again. Ethanol (20 ml) is added in a volume 2 times the weight of compound la to the concentrated solution, stirred at room temperature for 10 to 20 hours, and filtered. During filtration, ethanol (20 ml) is used in a volume 2 times the weight of compound la cooled to 0 to 10°C as the washing liquid, and the obtained solid is vacuum-dried to obtain the title compound (purity 97.07%, overall yield of steps 1 to 3 33.91%). Example 2 - Preparation of finerenone

[0092] (Step!) (S)— 4— (4 —shi 0{No-1-2-methoxyphenyl)-1-5-ethoxy-1-2,8-dimethyl-1-1-4-dihydro-1-6 ■ Preparation of di-p-toluoyl-D-tartaric acid salt of naphthyridine-3-carboxylic acid (Compound 2a) Compound 1 (10 g, 1.0 eq) obtained according to Preparation Example 1 and di-p-toluoyl-D-tartaric acid (2.8 g, 0.55 eq) were added to ethanol (2000 ml) in a volume 200 times the weight of compound 1. After stirring at an internal temperature of 15 to 25°C for 20 hours, the mixture was filtered. The resulting solid was washed with ethanol (20 ml) in a volume twice the weight of compound 1 during filtration and vacuum-dried to obtain the title compound (optical purity 90.80%, yield 43.66%).

[0093] (Step 2) (S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4~dihydro-1,6 ■ Preparation of naphthyridine-3-carboxylic acid (compound la) The compound 2a obtained in the above step 1 was used to obtain the title compound through a process substantially the same as step 2 of Example 1 (overall yield of steps 1 and 2 39.29%).

[0094] (Step 3) Preparation of finerenone The compound la obtained in the above step 2 was used to obtain the title compound through a process substantially the same as step 3 of Example 1 (overall yield of steps 1 to 3: 33.40%). Example 3 - Preparation of finerenone

[0095] (Step 1) (S)— 4—(4 —shi 0Preparation of (-)-camphor-10-sulfonic acid salt of {no-1-2-methoxyphenyl)-1-5-ethoxy-1-2,8-dimethyl-1-1-4-dihydro-1,6-naphthyridine-3-carboxylic acid (compound 3) Compound 1, (10 g, 1.0 eq) obtained according to Preparation Example 1 and (-)-camphor-10-sulfonic acid (7.35 g, 1.2 eq) were added to ACN (5 to 10 ml) in a volume 5 to 10 times the weight of compound 1. The internal temperature was raised to 80°C, refluxed, and stirred for 1 hour. Subsequently, the mixture was cooled to 20 to 25°C for 1 hour, and then filtered. After washing with ACN (20 ml) in a volume twice the weight of compound 1 during filtration, the obtained solid was vacuum-dried to obtain the title compound (optical purity 98.86%, yield 21.96%). iH NMR (500 MHz, DMS0-d6) 6 ppm 0.74 (s, 3H), 1.04 ( ^7.08

[0096] Hz, 3H), 1.24 - 1.30(m, 2H), 1.81 - 1.87 (m, 2H), 1.93 (t, 4.64 Hz, IH), 2.20(s, 3H), 2.21 - 2.23 (m, IH), 2.36 - 2.40 (m, 4H), 2.67 (t, ^10.99 Hz, IH), 2.86(s, IH), 4.06 - 4.13(m, IH), 4.14 - 4.21(m, IH), 5.32(s, IH), 7.30 - 7.31(m, IH), 7.36(s, IH), 7.67(s, IH), 8.53(br s, IH).

[0097] (Step 2) Preparation of (S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4~dihydro-1,6-naphthyridine-3-carboxylic acid (compound la) The title compound was obtained as a solid through a process substantially the same as step 2 of example 1 except that compound 3 obtained in step 1 was used (overall yield of steps 1 and 2: 20.11%).

[0098] (Step 3) Preparation of finerenone The compound la obtained in step 2 was used to obtain the title compound as a solid through a process substantially the same as step 3 of Example 1 (total yield of steps 1 to 3: 17.09%). Example 4 - Preparation of finerenone

[0099] (Step !) (S)— 4—(4 —shi 0 {No-1-2-methoxyphenyl}-5-ethoxy-1-2,8-dimethyl-1-1-4-dihydro-1-6 ■ Preparation of di-p-toluoyl-D-tartaric acid salt of naphthyridine-3-carboxylic acid (compound 2a) Through a process substantially the same as step 1 of Example 1, the title compound was obtained as a solid (optical purity 93-94%, yield 44.34%).

[0100] (Step 2) In Step 2 of the manufacture of finerenone, compound 2a (10 g, 1.0 eq), EDC I (3.76 g, 1.5 eq), DMAP (2.39 g, 1.5 eq), and 25% NH40H aqueous solution (10.4 to 31.2 ml, 5 to 15 eq) obtained in Step 1 were added to EA (100 ml) in a volume 10 times the weight of compound 2a, and the temperature was raised to 70 to 80°C and refluxed. After 1 to 2 hours of reaction, when compound 1a remained less than 1%, the reaction was terminated, and work-up was performed using EA (200 ml) and water (200 ml) in a volume 20 times the weight of compound 2a, respectively, and the resulting mixture was concentrated. Ethanol (50 ml) was added in a volume 5 times the weight of compound 2a, concentrated again, and ethanol (20 ml) was added in a volume 2 times the weight of compound 2a to the concentrated solution, stirred at room temperature for 10 to 20 hours, and then filtered. During filtration, ethanol (20 ml) was used in a volume 2 times the weight of compound 2a cooled to 10 °C or lower as the washing liquid, and the obtained solid was vacuum-dried to obtain the title compound (overall yield of steps 1 and 2 39.6%, purity 98.99%). Comparative Example 1 Substantially the same process as described in steps 1 and 2 of Example 1 was performed, except that dibenzoyl-L-tartaric acid was used instead of di-p-toluoyl-D-tartaric acid for compound 1 obtained according to Preparation Example 1. As a result, it was confirmed that compound lb was obtained as the main product. Comparative Example 2 A process substantially identical to that described in Step 1 of Example 3 was performed for Compound 1 obtained according to Manufacturing Example 1, except that D-(+)-camphoric acid was used instead of (-)-camphor-10-sulfonic acid. As a result, it was confirmed that Compound 3 was not produced.Characterization - Temperature stability The initial purity of compound 2a obtained according to an example of the present invention was confirmed, and the purity was measured at 1 day, 3 days, 5 days, 1 week, 2 weeks, 3 weeks, and 4 weeks while storing at 0°C, 25°C, and 50°C, respectively, for up to 4 weeks. As a result, it was confirmed that compound 2a did not substantially change from the initial purity until at least the 4th week even when stored at each of 0°C, 25°C, and 50°C, respectively. In addition, for compound 3 obtained according to an example of the present invention, in the same manner as compound 2a, when stored at 0°C, 25°C, and 50°C, respectively, for up to 4 weeks and compared with the initial purity, it was confirmed that there was substantially no change from the initial purity until at least the 4th week. Example 5 - Preparation of compound 1.

[0101] (Step 1) Compound 2b was obtained through a process substantially the same as Step 1 of Synthesis Example 1 of Compound 2b.

[0102] (Step 2) Synthesis of compound 1

[0103] (Step 2a) Oxidation of compound 2b - Preparation of compound 5 In the solid compound 2b (20 g, leq) obtained in step 1 of Example 1, ceric ammonium nitrate (Ceric ammonium ni trate; CAN, 1.5eq, 43.3 g) and ceric ammonium nitrate (CAN, 800 ml) in a volume 40 times the weight of compound 2b were added, and the mixture was stirred at room temperature for 1 to 3 hours. After the reaction was completed, EA (400 ml) and water (400 ml) were added in a volume 20 times the weight of compound 2b, respectively, and extracted. Subsequently, water (400 ml) was added to the EA layer in a volume 20 times the weight of compound 2b, and the EA layer was completely concentrated. Thereafter, the concentrated residue was vacuum-dried (3 g, yield 88.18% in step 2a). It was confirmed that the obtained result was compound 5.

[0104] (Step 2b) Reduction of Compound 5 - Preparation of Compound 1 The solid obtained in Step 2a (3 g, leq), zinc powder (15eq, 5.87 g), and ammonium formate (15eq, 5.66 g) were added to 75 ml of THF, which is 25 times the volume of the solid obtained in Step 2a, and the temperature was raised to 64 - 65°C, followed by refluxing for 1 - 2 hours. Subsequently, after cooling to 20°C, the zinc powder was filtered off. Then, 60 ml of EA, which is 20 times the volume of the solid obtained in Step 2a, 30 ml of water, which is 10 times the volume, and 30 ml of an aqueous NaCl solution, which is 10 times the volume, were added for extraction. After that, 60 ml of water, which is 20 times the volume of the solid obtained in Step 2a, was added to the EA layer for re - extraction. Also, 9 g of MgSO4, which is 3 times the weight of the solid obtained in Step 2a, was added to the EA layer, stirred for 5 minutes, and then filtered and concentrated. 6 ml of acetonitrile (ACN), which is 2 times the volume of the solid obtained in Step 2a, was added to the concentrated residue, and refluxed at about 75 - 80°C for 0.5 - 1 hour. Subsequently, after cooling to 20°C, it was stirred for 2 - 3 hours. After filtering the solid (washed with 6 ml of acetonitrile, which is 2 times the volume of the solid obtained in Step 2a), it was vacuum - dried (1.62 g, yield of Step 2b: 88.93%; total yield of Steps 1 and 2: 78.25%). It was confirmed that the obtained product was Compound 1, which is a non - chiral racemic mixture. Although the above has been described by referring to the preferred embodiments of the present invention, those skilled in the art will understand that the present invention can be variously modified and changed within the scope not departing from the spirit and scope of the present invention described in the following claims.

Claims

【Scope of Claims】 【 Claim 11 A method for producing finerenone, comprising: a step of producing compound 2a represented by chemical formula 2a or compound 3 represented by chemical formula 3 using compound 1 represented by chemical formula 1; and a step of producing finerenone represented by chemical formula I from compound 2a or compound 3: <화학식 1> 57 【

2. A method for preparing finerenone in claim 1, wherein the step of preparing compound 2a or compound 3 comprises a step of reacting compound 1 with di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid.

3. 58 A method for producing finerenone in claim 2, wherein compound 1 and di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid are reacted in the presence of acetonitrile. 【

4. A method for producing finerenone, wherein the step of producing compound 2a or compound 3 in claim 2 comprises a step of reacting compound 1 with di-p-toluoyl-D-tartaric acid or (-)-camphor-10-sulfonic acid at 15 to 90 °C.

5. In claim 1, the step of preparing compound 2a comprises reacting compound 1 and di-p-toluoyl-D-tartaric acid in the presence of at least one organic solvent selected from the group consisting of methanol, ethanol, THF, and acetonitrile. 59 A method for producing finerenone, comprising a reacting step.

6. A method for producing finerenone in claim 1, wherein the step of producing compound 3 comprises a step of reacting compound 1 with (-)-camphor-10-sulfonic acid in acetonitrile. 【

7. A method for producing finerenone in claim 6, wherein acetonitrile is mixed in a volume 10 times the weight of compound 1.

8. In claim 1, the step of manufacturing finerenone comprises: 60 A method for preparing finerenone, comprising the step of obtaining compound la represented by chemical formula la using compound 2a or compound 3: <화학식 la> 【A method for producing finerenone, wherein in claim 8, the step of obtaining the compound la is performed by adding disodium phosphate (NH2HP04) under an alcohol aqueous solution condition.

10. 61 A method for producing finerenone, wherein the step of producing finerenone in claim 1 comprises a step of obtaining finerenone by using compound 2a or compound 3 as a reactant of amide coupling.

11. A method for producing finerenone in claim 10, wherein the step of obtaining finerenone by using compound 2a or compound 3 as a reactant of amide coupling is performed by reacting 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 4-dimethylaminopyridine (DMAP), and ammonium hydroxide (NH4OH) with compound 2a or compound 3 in ethyl acetate (EA). 【Claim 1 is in claim 8, A method for producing finerenone, wherein the step of producing finerenone further includes a step of forming a salt in the obtained compound la to produce compound 2a or compound 3.

13. A method for producing finerenone in claim 12, wherein the step of producing compound 2a further includes the step of reacting compound la and di-p-toluoyl-D-tartaric acid in an equivalent ratio of 1:0.1 to 1:0.

9.

14. In claim 12, the step of preparing compound 2a comprises a step of reacting compound la and di-p-toluoyl-D-tartaric acid in the presence of at least one organic solvent selected from the group consisting of methanol and THF. A method for producing finerenone, comprising:

15. In claim 1, the method for producing finerenone further comprises the steps of: oxidizing compound 2b represented by chemical formula 2b to obtain compound 5 represented by chemical formula 5; and reducing compound 5 to obtain compound 1 represented by chemical formula 1. <화학식 2b>

16. An intermediate compound for producing finerenone, which is a compound 2a represented by the following chemical formula 2a or a compound 2b represented by the following chemical formula 2b: <화학식 2a>

17. A method for producing an intermediate compound for producing finerenone, comprising the step of reacting compound 1 represented by chemical formula 1 with di-p-toluoyl-D-tartaric acid to produce compound 2a represented by chemical formula 2a or compound 2b represented by chemical formula 2b: <화학식 1>

18. An intermediate compound for the production of finerenone, represented by the following chemical formula 3: <화학식 3> 【A method for producing an intermediate compound for producing finerenone, comprising the step of producing compound 3 represented by chemical formula by reacting compound 1 represented by chemical formula 1 with (-)-camphor-10-sulfonic acid: <Chemical Formula 1> 67

20. A method for producing compound 1 represented by chemical formula 1, comprising: a step of oxidizing compound 2b represented by chemical formula 2b to obtain compound 5 represented by chemical formula 5; and a step of reducing compound 5 to obtain compound 1 represented by chemical formula 1: <Chemical Formula 2b> <Chemical Formula 1> 【claim In Article 20, 69 The step of obtaining the above compound 5 is to prepare compound 2b and ceric ammonium nitrate. A method for producing compound 1 represented by chemical formula 1, which is performed by reacting (ceric ammonium nitrate, CAN) in acetonitrile. 【Claim 2: A method for producing compound 1 represented by chemical formula 1, wherein the step of obtaining compound 1 is performed by reacting compound 5, zinc powder, and ammonium formate in THF. 70

Citation Information

Patent Citations

  • Method for preparing fenerenone and intermediates thereof

    CN115340540A

  • Optically active 1,6-naphthyridine derivatives

    KR100219251B1

  • New intermediates of Voriconazole and preparation of Voriconazole using the same

    KR101109215B1

  • Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof

    KR101614164B1

  • Vehicle Recognition Optimization Apparatus of AI-based Domain Adaptive Parking Control System and Driving Method Thereof

    KR102491217B1